Last reviewed · How we verify

NCT03914846

Ultrasound in Diagnosing Patients With Skin Lesions

Completed NA Last updated 30 January 2024
What this trial tests

NA trial testing Ultrasound in Skin Lesion in 47 participants. Completed in 20 October 2022.

Timeline
29 April 2019
Primary endpoint
20 October 2022
20 October 2022

Quick facts

Lead sponsorEmory University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment47
Start date29 April 2019
Primary completion20 October 2022
Estimated completion20 October 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Emory University

Who can join

18 and older, any sex, with Skin Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial studies the use of a novel non-invasive ultrasound technique in diagnosing patents with skin lesions. Diagnostic procedures, such as ultrasound, may be a less invasive way to check skin lesions for skin cancer and other skin disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Skin Lesion

Currently open trials in the same condition.

Other Emory University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03914846.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing